Comment
doi: 10.1038/ncpendmet0348.
Osteonecrosis of the jaw--a potential adverse effect of bisphosphonate treatment
Affiliations
- PMID: 17143310
- DOI: 10.1038/ncpendmet0348
Item in Clipboard
Comment
Osteonecrosis of the jaw--a potential adverse effect of bisphosphonate treatment
Nat Clin Pract Endocrinol Metab.
2006 Dec.
No abstract available
Comment on
-
Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.Ann Intern Med. 2006 May 16;144(10):753-61. doi: 10.7326/0003-4819-144-10-200605160-00009. Ann Intern Med. 2006. PMID: 16702591 Review.
Similar articles
-
Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.J Oral Maxillofac Surg. 2008 Feb;66(2):223-30. doi: 10.1016/j.joms.2007.09.019. J Oral Maxillofac Surg. 2008. PMID: 18201600
-
Bisphosphonate-associated osteonecrosis can hide jaw metastases.Bone. 2007 Dec;41(6):942-5. doi: 10.1016/j.bone.2007.08.025. Epub 2007 Aug 29. Bone. 2007. PMID: 17905677
-
Osteonecrosis of the jaw due to bisphosphonates.Prescrire Int. 2008 Oct;17(97):202-3. Prescrire Int. 2008. PMID: 19536938
-
Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Sep;108(3):e1-8. doi: 10.1016/j.tripleo.2009.04.027. Epub 2009 Jul 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009. PMID: 19570696 Review.
-
Osteonecrosis of the jaw and bisphosphonates: a comparison with white phosphorus, radium, and osteopetrosis.Clin Toxicol (Phila). 2007 Oct-Nov;45(7):753-62. doi: 10.1080/15563650701232505. Clin Toxicol (Phila). 2007. PMID: 17852160 Review.
Cited by
-
[Position paper on medication-related osteonecrosis of the jaw (MRONJ)].Wien Med Wochenschr. 2016 Feb;166(1-2):68-74. doi: 10.1007/s10354-016-0437-2. Wien Med Wochenschr. 2016. PMID: 26847441 German.
-
[Metabolic bone diseases].Internist (Berl). 2007 Oct;48(10):1101-17. doi: 10.1007/s00108-007-1934-6. Internist (Berl). 2007. PMID: 17882394 German.
-
Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.Clin Oral Investig. 2017 Jan;21(1):127-134. doi: 10.1007/s00784-016-1762-y. Epub 2016 Feb 29. Clin Oral Investig. 2017. PMID: 26924135
-
Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment - a grossly underestimated risk?Clin Oral Investig. 2013 Nov;17(8):1829-37. doi: 10.1007/s00784-012-0873-3. Epub 2012 Nov 1. Clin Oral Investig. 2013. PMID: 23114879
-
Odanacatib, a new drug for the treatment of osteoporosis: review of the results in postmenopausal women.J Osteoporos. 2010 Jun 14;2010:401581. doi: 10.4061/2010/401581. J Osteoporos. 2010. PMID: 20948576 Free PMC article.